PuSH - Publikationsserver des Helmholtz Zentrums München

Gerlach, K.* ; Daniel, C. ; Lehr, H.A.* ; Nikolaev, A.* ; Gerlach, T.* ; Atreya, R.* ; Rose-John, S.* ; Neurath, M.F.* ; Weigmann, B.*

Transcription factor NFATc2 controls the emergence of colon cancer associated with IL-6-dependent colitis.

Cancer Res. 72, 4340-4350 (2012)
Verlagsversion Volltext DOI
Free by publisher
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
NFAT transcription factors control T-cell activation and function. Specifically, the transcription factor NFATc2 affects the regulation of cell differentiation and growth and plays a critical role in the development of colonic inflammation. Here, we used an experimental model of colitis-associated colorectal carcinoma to investigate the contribution of NFATc2 to the promotion of colonic tumors. Compared with wild-type animals that readily presented with multiple colon tumors, NFATc2-deficient mice were protected from tumor development. This observed decrease in colonic tumor progression was associated with reduced endoscopic inflammation, increased apoptosis of lamina propria T lymphocytes, and significantly reduced levels of the critical proin-flammatory cytokines interleukin (IL)-21 and IL-6. Administration of hyper IL-6 abrogated protection from tumor progression in NFATc2-knockout mice and restored tumor incidence to control levels. Taken together, our findings highlight a pivotal role for NFATc2 in the establishment of inflammation-associated colorectal tumors mediated by control of IL-6 expression.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter CHRONIC INTESTINAL INFLAMMATION; T-CELL-ACTIVATION; COLORECTAL-CANCER; ULCERATIVE-COLITIS; SIGNALING PATHWAY; TUMOR PROGRESSION; NUCLEAR FACTOR; BOWEL-DISEASE; IN-VIVO; EXPRESSION
ISSN (print) / ISBN 0008-5472
e-ISSN 1538-7445
Zeitschrift Cancer Research
Quellenangaben Band: 72, Heft: 17, Seiten: 4340-4350 Artikelnummer: , Supplement: ,
Verlag American Association for Cancer Research (AACR)
Verlagsort Philadelphia, Pa.
Begutachtungsstatus